GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » BBS-Bioactive Bone Substitutes PLC (OHEL:BONEH) » Definitions » Retained Earnings

BBS-Bioactive Bone Substitutes (OHEL:BONEH) Retained Earnings : €-22.11 Mil (As of Dec. 2023)


View and export this data going back to 2018. Start your Free Trial

What is BBS-Bioactive Bone Substitutes Retained Earnings?

Retained earnings is the accumulated portion of net income that is not distributed to shareholders. BBS-Bioactive Bone Substitutes's retained earnings for the quarter that ended in Dec. 2023 was €-22.11 Mil.

BBS-Bioactive Bone Substitutes's quarterly retained earnings declined from Dec. 2022 (€-18.63 Mil) to Jun. 2023 (€-20.27 Mil) and declined from Jun. 2023 (€-20.27 Mil) to Dec. 2023 (€-22.11 Mil).

BBS-Bioactive Bone Substitutes's annual retained earnings declined from Dec. 2021 (€-15.54 Mil) to Dec. 2022 (€-18.63 Mil) and declined from Dec. 2022 (€-18.63 Mil) to Dec. 2023 (€-22.11 Mil).


BBS-Bioactive Bone Substitutes Retained Earnings Historical Data

The historical data trend for BBS-Bioactive Bone Substitutes's Retained Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BBS-Bioactive Bone Substitutes Retained Earnings Chart

BBS-Bioactive Bone Substitutes Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Retained Earnings
Get a 7-Day Free Trial Premium Member Only -10.03 -12.77 -15.54 -18.63 -22.11

BBS-Bioactive Bone Substitutes Semi-Annual Data
Dec15 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Retained Earnings Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -15.54 -17.21 -18.63 -20.27 -22.11

BBS-Bioactive Bone Substitutes Retained Earnings Calculation

Retained Earnings is the accumulated portion of net income that is not distributed to shareholders. Because the net income was not distributed to shareholders, shareholders' equity is increased by the same amount.

Of course, if a company loses, it is called retained losses, or accumulated losses.


BBS-Bioactive Bone Substitutes  (OHEL:BONEH) Retained Earnings Explanation

Historically profitable companies sometimes have negative retained earnings. This is because they have cumulatively paid out more to shareholders than they reported in profits.

For example, in 2011, Microsoft had negative retained earnings. This does not mean the company lost more money than it made over the years. It just means it paid out more money than it earned.

If a company has negative retained earnings, investors should check the 10-year financial results. They should not assume that negative retained earnings prove a company has generally lost money in the past.

Of course, many companies with negative retained earnings have indeed lost money in the past.

Retained Earnings: Warren Buffett's Secret.

One of the most important indicators of durable competitive advantage. Net earnings can be paid out as dividends, used to buy back shares or retained for growth.

If the company loses more than it has accumulated, retained earnings is negative.

If a company isn't adding to its retained earnings, it isn't growing its net worth.

Rate of growth of retained earnings is good indicator whether it's benefiting from a competitive advantage.

Microsoft is negative because it chose to buyback stock and pay dividends.

The more earnings retained, the faster it grows and increases growth rate for future earnings.


BBS-Bioactive Bone Substitutes (OHEL:BONEH) Business Description

Traded in Other Exchanges
N/A
Address
Kiviharjunlenkki 6, Oulu, FIN, 90220
BBS-Bioactive Bone Substitutes PLC is a health technology company, that develops, designs, and manufactures bioactive bone-graft substitute implants. Its ortho-biological product ARTEBONE, which is based on tricalcium phosphate and a natural spectrum of bone proteins has the capability of bone regeneration.

BBS-Bioactive Bone Substitutes (OHEL:BONEH) Headlines

No Headlines